Randomised, Double-blind, Placebo-controlled, Phase IIa Dose Finding Study of Single Dose GHB11L1 in Healthy Adults.

Trial Profile

Randomised, Double-blind, Placebo-controlled, Phase IIa Dose Finding Study of Single Dose GHB11L1 in Healthy Adults.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2014

At a glance

  • Drugs Influenza virus delta-NS1 vaccine (Primary)
  • Indications Influenza A virus H1N1 subtype; Influenza A virus H5N1 subtype; Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors AVIR Green Hills Biotechnology
  • Most Recent Events

    • 04 Jan 2011 Actual initiation date changed from 13 Jan 2010 to Dec 2009 as reported by ClinicalTrials.gov.
    • 04 Jan 2011 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
    • 04 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top